Molnupiravir is considered a potential antiviral treatment for COVID-19. This innovative drug acts to inhibit the replication of the SARS-CoV-2 virus, aiming to decrease the severity of illness. Clinical trials have https://www.milanmedicals.com/molnupiravir-200-mg